Save your place

Sign in to WhoBought

Please try again later.

Iovance Biotherapeutics, Inc. (IOVA) institutional ownership

Latest close $5.13 Jul 23, 2026
Market cap$895M 52-week range SectorHealthcare
Funds holding · Q1 2026
271
reported IOVA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
175 buyers · 96 sellers

Iovance Biotherapeutics, Inc. (IOVA) price and institutional activity

Dates

Q1 2026

$0 bought by 175 investors
Two Sigma Investments, LPD. E. Shaw & Co., Inc. +173 more
$0 sold by 96 investors
Long Focus Capital Management, LLCBank of America Corp +94 more
Bought Sold Totals per quarter; hover a bar for the names.

Iovance Biotherapeutics, Inc. (IOVA) institutional activity · 271

Investor Type Est. change Change Δ Own Date
Two Sigma Investments, LP · Added
Change +9.3M Δ Own +211.2% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +9.3M +211.2% Q1 2026
Long Focus Capital Management, LLC · Reduced
Change −6.5M Date Q1 2026
Long Focus Capital Management, LLC Reduced· Q1 2026 −6.5M Q1 2026
Bank of America Corp · Reduced
Change −5.8M Date Q1 2026
Bank of America Corp Reduced· Q1 2026 −5.8M Q1 2026
D. E. Shaw & Co., Inc. · Added
Change +4.2M Δ Own +109.3% Date Q1 2026
D. E. Shaw & Co., Inc. Added· Q1 2026 +4.2M +109.3% Q1 2026
Vanguard · Added
Change +3.7M Date Q1 2026
Vanguard Added· Q1 2026 +3.7M Q1 2026
Invenomic Capital Management LP · Reduced
Change −3.5M Date Q1 2026
Invenomic Capital Management LP Reduced· Q1 2026 −3.5M Q1 2026
Two Sigma Advisers, LP · Exited
Change −3.0M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −3.0M −100.0% Q1 2026
Morgan Stanley · Reduced
Change −3.0M Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −3.0M Q1 2026
Millennium Management LLC · Added
Change +2.8M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +2.8M Q1 2026
State Street · Reduced
Change −2.7M Date Q1 2026
State Street Reduced· Q1 2026 −2.7M Q1 2026
Marshall Wace, LLP · New
Change +2.4M Date Q1 2026
Marshall Wace, LLP New· Q1 2026 +2.4M Q1 2026
Nuveen, LLC · Added
Change +2.3M Date Q1 2026
Nuveen, LLC Added· Q1 2026 +2.3M Q1 2026
T. Rowe Price Associates · Added
Change +2.0M Date Q1 2026
T. Rowe Price Associates Added· Q1 2026 +2.0M Q1 2026
Susquehanna International Group, LLP · Reduced
Change −2.0M Date Q1 2026
Susquehanna International Group, LLP Reduced· Q1 2026 −2.0M Q1 2026
Knott David M Jr · New
Change +1.6M Date Q1 2026
Knott David M Jr New· Q1 2026 +1.6M Q1 2026
Data through Q1 2026 · filed Jun 9, 2026
15 of 271

Famous investor activity in Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics, Inc. (IOVA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Weiser Michael · Director Grant (A) 90K
Owned 90K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Weiser Michael Director Grant (A) 90K 90K Jun 16, 2026 Jun 18, 2026
Dukes Iain D. · Director Grant (A) 181K
Owned 181K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Dukes Iain D. Director Grant (A) 181K 181K Jun 16, 2026 Jun 18, 2026
Countouriotis Athena · Director Grant (A) 90K
Owned 90K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Countouriotis Athena Director Grant (A) 90K 90K Jun 16, 2026 Jun 18, 2026
Maynard Ryan D. · Director Grant (A) 90K
Owned 90K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Maynard Ryan D. Director Grant (A) 90K 90K Jun 16, 2026 Jun 18, 2026
Puri Raj K. · Officer Grant (A) 15K
Owned 15K Trade date Jun 16, 2026 Filed date Jun 18, 2026
Puri Raj K. Officer Grant (A) 15K 15K Jun 16, 2026 Jun 18, 2026
Vogt Frederick G. · Director 2 operations 0
Owned 109K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Vogt Frederick G. Director 2 operations 0 109K Jun 5, 2026 Jun 9, 2026
Vogt Frederick G. · Director Tax withholding or exercise payment (F) -$28K
Price $4.23 Qty -7K Owned 562K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Vogt Frederick G. Director Tax withholding or exercise payment (F) $4.23 -7K -$28K 562K Jun 5, 2026 Jun 9, 2026
Graf Finckenstein Friedrich · Officer 2 operations 0
Owned 55K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Graf Finckenstein Friedrich Officer 2 operations 0 55K Jun 5, 2026 Jun 9, 2026
Graf Finckenstein Friedrich · Officer Tax withholding or exercise payment (F) -$17K
Price $4.23 Qty -4K Owned 140K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Graf Finckenstein Friedrich Officer Tax withholding or exercise payment (F) $4.23 -4K -$17K 140K Jun 5, 2026 Jun 9, 2026
Puri Raj K. · Officer 2 operations 0
Owned 68K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Puri Raj K. Officer 2 operations 0 68K Jun 5, 2026 Jun 9, 2026
Puri Raj K. · Officer Tax withholding or exercise payment (F) -$16K
Price $4.23 Qty -4K Owned 248K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Puri Raj K. Officer Tax withholding or exercise payment (F) $4.23 -4K -$16K 248K Jun 5, 2026 Jun 9, 2026
Bilinsky Igor · Officer 2 operations 0
Owned 55K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Bilinsky Igor Officer 2 operations 0 55K Jun 5, 2026 Jun 9, 2026
Bilinsky Igor · Officer Tax withholding or exercise payment (F) -$17K
Price $4.23 Qty -4K Owned 134K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Bilinsky Igor Officer Tax withholding or exercise payment (F) $4.23 -4K -$17K 134K Jun 5, 2026 Jun 9, 2026
Vogt Frederick G. · Director 2 operations 0
Owned 125K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Vogt Frederick G. Director 2 operations 0 125K Jun 1, 2026 Jun 3, 2026
Vogt Frederick G. · Director Tax withholding or exercise payment (F) -$70K
Price $3.96 Qty -18K Owned 554K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Vogt Frederick G. Director Tax withholding or exercise payment (F) $3.96 -18K -$70K 554K Jun 1, 2026 Jun 3, 2026
15 of 72
15 of 72 Sign in to continue to older insider transactions.

Iovance Biotherapeutics, Inc. (IOVA) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Quogue Capital LLC 30.0M
% of shares outstanding 11.6% Filing date Mar 19, 2024
Quogue Capital LLC 30.0M 11.6% Mar 19, 2024
The Vanguard Group 25.1M
% of shares outstanding 7.5% Filing date Jul 29, 2025
The Vanguard Group 25.1M 7.5% Jul 29, 2025
BlackRock Inc. 19.1M
% of shares outstanding 7.5% Filing date Jan 26, 2024
BlackRock Inc. 19.1M 7.5% Jan 26, 2024
Mhr Fund Management LLC 17.6M
% of shares outstanding 6.9% Filing date Feb 9, 2024
Mhr Fund Management LLC 17.6M 6.9% Feb 9, 2024
Avoro Capital Advisors LLC 7.0M
% of shares outstanding 4.4% Filing date Feb 14, 2023
Avoro Capital Advisors LLC 7.0M 4.4% Feb 14, 2023
State Street Corporation 17.4M
% of shares outstanding 4.2% Filing date May 12, 2026
State Street Corporation 17.4M 4.2% May 12, 2026
Perceptive Advisors LLC 12.8M
% of shares outstanding 3.8% Filing date May 15, 2025
Perceptive Advisors LLC 12.8M 3.8% May 15, 2025
Franklin Resources Inc 5.8M
% of shares outstanding 3.7% Filing date Feb 4, 2022
Franklin Resources Inc 5.8M 3.7% Feb 4, 2022
8 of 11

Iovance Biotherapeutics, Inc. (IOVA) ownership FAQ

Who owns IOVA?

271 reporting institutions disclosed IOVA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.